EichorEICHOR
Study identifier: NCT06058546 Synced from ClinicalTrials.gov · August 04, 2026
● Recruiting

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Condition: Plaque Psoriasis  ·  Sponsor: Tasly Pharmaceutical Group Co., Ltd

PhasePhase 2
Planned participants180
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

This description comes directly from the study's public registry record.

Talk to the study team

Rui Liu  ·  022-86343626  ·  liurui2@tasly.com

Always discuss trial participation with your own doctor first.

Locations (12)

Beijing traditional Chinese medicine hospital affiliated to Capital Medical UniversityBeijing, ChinaRecruiting
Affiliated Hospital of Changchun University of Traditional Chinese MedicineChangchun, ChinaRecruiting
The First Affiliated Hospital of Hunan University of Chinese MedicineChangsha, ChinaRecruiting
Chengdu Second People's HospitalChengdu, ChinaRecruiting
Affiliated Hospital of Shandong University of Traditional Chinese MedicineJinan, ChinaRecruiting
Yunnan Provincial Hospital of Traditional Chinese MedicineKunming, ChinaRecruiting
Nanyang First People's HospitalNanyang, ChinaRecruiting
The First Affiliated Hospital of China Medical UniversityShenyang, ChinaRecruiting
Affiliated Hospital of Tianjin Institute of Traditional Chinese MedicineTianjin, ChinaRecruiting
First affiliated hospital of Wenzhou medical universityWenzhou, ChinaRecruiting
The Second Affiliated Hospital of Xiamen Medical CollegeXiamen, ChinaRecruiting
Xingtai people's hospitalXingtai, ChinaRecruiting

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →